Concepedia

Danielle Raufaste

DR

Statistics

Publications

17

Citations

1.2K

H-Index

16

Active since

1991

Affiliations

Sanofi (France)(Current)

Inserm

Hôpitaux Universitaires Henri-Mondor

Danielle Raufaste is an author at Sanofi (France) specializing in pharmacology, cell signaling, and vasopressin receptor pharmacology.

Publications per year

1991–2007

17

Publications

17

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. Serradeil‐Le Gal, C Lacour, G Valette et al. · Journal of Clinical Investigation · 1996 · 249 citations · Full text

, , +11

Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway.

Ariane Mallat, Laura Fouassier, Anne-Marie Préaux et al. · Journal of Clinical Investigation · 1995 · 110 citations · Full text

, , +15

Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

C. Serradeil‐Le Gal, Catherine Jouneaux, A Sanchez-Bueno et al. · Journal of Clinical Investigation · 1991 · 110 citations · Full text

, , +13

Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.

Ariane Mallat, Anne-Marie Préaux, C. Serradeil‐Le Gal et al. · Journal of Clinical Investigation · 1996 · 104 citations · Full text

, , +14

Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

Claudine Serradeil-Le Gal, Max Lafontan, Danielle Raufaste et al. · FEBS Letters · 2000 · 75 citations

, , +17

1–5 of 17